Demet Tekcan

Demet Tekcan

Auto-generated profile, based on publicly available information

Demet Tekcan

Division of Pediatric Immunology and Allergy, Department of Pediatrics Konya Beyhekim Training and Research Hospital Konya Turkey

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2025 in Revue Française d'Allergologie
Verified
Journal Article
Closed access
DTD. Tekcan
D. Tekcan
ICI. Kulhas Celik
I. Kulhas Celik
HAHasibe Artaç
Hasibe Artaç

16 June 2026 in Revue Française d'Allergologie
Verified
Journal Article
Closed access
DTD. Tekcan
D. Tekcan
ICI. Kulhas Celik
I. Kulhas Celik
HAHasibe Artaç
Hasibe Artaç

1 January 2026 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
DTDemet Tekcan
Demet Tekcan
SSSadiye Sert
Sadiye Sert
EBEbru Buldu
Ebru Buldu
AAAyşe Hümeyra Akgül
Ayşe Hümeyra Akgül
HCHakan Candan
Hakan Candan

25 September 2025 in Revue Française d'Allergologie
Verified
Journal Article
Closed access
ŞKŞ.İ. Kökcü Karadağ
Ş.İ. Kökcü Karadağ
DTD. Tekcan
D. Tekcan
HNHulya Nalcacioglu
Hulya Nalcacioglu
ÖAÖ. Aydoğ
Ö. Aydoğ
FÖF. Öztürk
F. Öztürk

21 March 2026 in International Archives of Allergy and Immunology
Verified
Journal Article
Closed access
PDF file
DTDemet Tekcan
Demet Tekcan
ICIlknur Kulhas Celik
Ilknur Kulhas Celik
HAHasibe Artac
Hasibe Artac
Introduction: Cow’s milk allergy (CMA) and egg allergy (EA) are among the most common food allergies in childhood. Although measles, mumps, and rubella (MMR) vaccination is generally considered safe in food-allergic children, uncertainty persists among clinicians and families regarding the clinical relevance of residual food proteins in different MMR vaccine formulations. This study aimed to evaluate adverse reactions following administration of two different MMR vaccines in children with confirmed CMA and/or EA and to explore implications for safe immunization practices. Methods: We retrospectively analyzed 140 children with diagnosed CMA and/or EA who received the MMR vaccine at our pediatric allergy clinic between September 2022 and May 2025. Demographic data, allergen-specific IgE levels, skin prick test results, MMR vaccine type and postvaccination reactions, were recorded. Two formulations were used: the Serum Institute of India vaccine (α-lactalbumin-containing) and Priorix® (α-lactalbumin-free). Results: Among the patients, EA was observed in 60%, CMA in 17.1%, and both in 22.9%. Atopic dermatitis was present in 56.4%, urticaria in 31.4%, and a history of anaphylaxis in 12.1%. Overall, 57.9% (n = 81) received the α-lactalbumin-containing vaccine, while 42.1% (n = 59) received Priorix®. Only 1 (0.7%) patient experienced anaphylaxis after vaccination with the α-lactalbumin-containing formulation. No other serious adverse reactions were recorded. Conclusion: MMR vaccination was generally well tolerated in children with egg and/or CMA. While rare immediate reactions may occur with vaccines containing milk-derived proteins, these findings support continued adherence to current vaccination recommendations, with awareness of vaccine composition and appropriate vaccination settings rather than vaccine avoidance.

12 December 2024 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
DTDemet Tekcan
Demet Tekcan
ICIlknur Kulhas Celik
Ilknur Kulhas Celik
MÖMerih Önal
Merih Önal
HAHasibe Artaç
Hasibe Artaç